Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

802.63
-8.8828-1.09%
Number of Gainers:19
Number of Losers:32
Number of Flat:3
PE:- -
High:811.54
Open:811.20
Low:801.75
Close:811.51
Volume:62.16M
Turnover:647.66M
Market Cap:137.13B
Float Cap:84.54B

Loading ...

Top Midday Decliners

MT Newswires Live
·
Aug 25

Alert Incorrectly Tagged to RPC Inc Withdrawn

Reuters
·
Aug 25

RPC Acquires Peracidin® Product Line

THOMSON REUTERS
·
Aug 24

Why Is NAPCO Security Stock Soaring Monday?

Benzinga Earnings
·
Aug 24

Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 24

Enerya Enerji and TGS Dis Ticaret Declare Cash Dividends Effective August 25, 2026

TIPRANKS
·
Aug 24

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access

MT Newswires Live
·
Aug 24

GOLDWAY EDU Completes Share Placement, Raising Approximately HK$4.4 Million Net

Stock News
·
Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Humacyte Says Phase 3 V012 Trial Shows ATEV Extends Catheter-Free Dialysis Time in Women

Reuters
·
Aug 24

Humacyte - Seeks to Add Dialysis Access as Second Approved Indication for Atev

THOMSON REUTERS
·
Aug 24

Humacyte - Supplemental Bla to be Supported by Three Phase 3 Studies of Atev

THOMSON REUTERS
·
Aug 24

Humacyte - to File Supplemental Bla with FDA for Atev in Dialysis Access in November 2026

THOMSON REUTERS
·
Aug 24

Humacyte Confirms Plans for Atev Supplemental Bla Filing for Dialysis Access Following FDA Discussions

THOMSON REUTERS
·
Aug 24

Napco Security Soars After Robust Q4 Results

Reuters
·
Aug 24

Regenxbio Shares Down 25% Premarket After FDA Places Clinical Hold on Co's Gene Therapy for Hunter Syndrome

THOMSON REUTERS
·
Aug 24

Regenxbio reports FDA placed clinical hold on RGX-121

TIPRANKS
·
Aug 24

NAPCO Security Technologies Raises Quarterly Dividend by 13%

Dow Jones
·
Aug 24

NAPCO Q4 Revenue Beats on Recurring Service Rev Growth

Reuters
·
Aug 24